Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Toshiko, Motoji"'
Publikováno v:
Internal Medicine. 62:697-701
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65d502d2a9e3b171e37d2f006667aaab
https://doi.org/10.2169/internalmedicine.9359-22
https://doi.org/10.2169/internalmedicine.9359-22
Autor:
Takeshi Odajima, Minoko Takanashi, Hiroki Sugimori, Taiko Tanba, Kentaro Yoshinaga, Toshiko Motoji, Masaya Munakata, Kazunori Nakajima, Mutsuhiko Minami
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148854 (2016)
We conducted a cross-sectional study to elucidate factors contributing to vasovagal reaction (VVR), the most frequent side effect following whole blood and apheresis donations. Complications recorded at the collection sites after voluntary donations
Externí odkaz:
https://doaj.org/article/be788343c5354a9397b5a815a045c34c
Publikováno v:
Genetics and Molecular Biology, Vol 31, Iss 2, Pp 427-430 (2008)
A unique mutation of the JAK2 gene, V617F, has recently been identified in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. To determine the relevance of this mutation in other types of hematological neoplasms i
Externí odkaz:
https://doaj.org/article/888b02e42f054ba69e036b7b125d88f6
Autor:
Naoki Mori, Mari Ohwashi, Kentaro Yoshinaga, Kenjiro Mitsuhashi, Norina Tanaka, Masanao Teramura, Michiko Okada, Masayuki Shiseki, Junji Tanaka, Toshiko Motoji
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80088 (2013)
L265P mutation in the MYD88 gene has recently been reported in Waldenström's macroglobulinemia; however the incidence has been different according to the methods used. To determine the relevance and compare the incidence by different methods, we ana
Externí odkaz:
https://doaj.org/article/1a66fa36c3ea475dacc84c213ee802da
Publikováno v:
Chromosome Science; 2022, Vol. 25 Issue 3/4, p51-56, 6p
Autor:
Kazue Tsuji, Yan-Hua Wang, Minoko Takanashi, Tsuyoshi Odajima, Gabriel A. Lee, Hiroki Sugimori, Toshiko Motoji
Publikováno v:
Hematology Reports, Vol 4, Iss 3, Pp e18-e18 (2012)
Lung resistance-related protein (LRP) and P-glycoprotein (P-gp) are associated with multidrug resistance. P-gp overexpression reduces intracellular anticancer drug concentrations and is correlated with low remission rates. However, whether the presen
Externí odkaz:
https://doaj.org/article/faa0aaa7ec7d4921a6b0d47973b7c193
Autor:
Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda, Takashi Sugihara, Kensuke Usuki, Tatsuya Kawaguchi, Noriko Usui, Shinichiro Okamoto, Yokiko Ohe, Shigeki Ohtake, Kunio Kitamura, Masahide Yamamoto, Hirofumi Teshima, Toshiko Motoji, Toshiharu Tamaki, Kenichi Sawada, Kazuma Ohyashiki
Publikováno v:
Haematologica, Vol 97, Iss 6 (2012)
It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myelo
Externí odkaz:
https://doaj.org/article/098a34917a454b42b4a4f7f57354be4c
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Primary bone marrow diffuse large B-cell lymphoma (DLBCL) is a rare type of extranodal lymphoma with poor prognosis. Here, we report a case of primary bone marrow DLBCL successfully treated with high-dose chemotherapy and rescued by in vivo rituximab
Externí odkaz:
https://doaj.org/article/ce73eaa5c5e24b59990014b20ab6da2e
Autor:
Masayuki Shiseki, Akihiro Masuda, Norimichi Watanabe, Masami Fujii, Tomofumi Kimura, Kentaro Yoshinaga, Naoki Mori, Masanao Teramura, Toshiko Motoji
Publikováno v:
Hematology Reports, Vol 3, Iss 2, Pp e10-e10 (2011)
Waldenström’s macroglobulinemia (WM)/ lymphoplasmacytic lymphoma (LPL) is an indolent mature B-cell neoplasm. In rare cases of WM/LPL, diffuse large B-cell lymphoma (DLBCL) develops as a result of histologic transformation. In this report, we pres
Externí odkaz:
https://doaj.org/article/688a9e91bfd64f13898410ca461dd20d
Autor:
Naoki Mori, Kentaro Yoshinaga, Michiko Okada, Mari Ohwashi-Miyazaki, Junji Tanaka, Toshiko Motoji, Masayuki Shiseki
Publikováno v:
European Journal of Haematology. 98:467-477
Objectives We previously reported loss of heterozygosity on 1p in chronic myelogenous leukemia (CML). We analyzed promoter methylation and mutation of tumor suppressor genes on 1p36 in CML. Methods We performed methylation-specific PCR (MS-PCR) analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193eae2ddff3135a5d3965c730c10a7b
https://doi.org/10.1111/ejh.12857
https://doi.org/10.1111/ejh.12857